Financial Ratios

KAPPAC PHARMA LTD.

NSE : NABSE : 506938ISIN CODE : INE601D01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE112.850 (0 %)
PREV CLOSE ( ) 112.85
OPEN PRICE ( ) 112.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 112.85 (554637)
VOLUME 76
TODAY'S LOW / HIGH ( )112.85 112.85
52 WK LOW / HIGH ( ) 112.85112.85
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.03-0.04-0.03-0.02-0.17
   CEPS(Rs)-0.03-0.04-0.03-0.02-0.17
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)12.5910.0510.0910.1212.50
   Tax Rate(%)0.000.000.000.00-0.16
Margin Ratios
   Core EBITDA Margin(%)
   EBIT Margin(%)
   Pre Tax Margin(%)
   PAT Margin (%)
   Cash Profit Margin (%)
Performance Ratios
   ROA(%)-0.26-0.32-0.24-0.25-0.15
   ROE(%)-0.27-0.35-0.26-0.42-2.79
   ROCE(%)-0.27-0.33-0.24-0.26-0.16
   Asset Turnover(x)0.000.000.000.000.00
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.000.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)
   Receivable days
   Inventory Days
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.00-1612.39-645.49-1519.73-256.52
   Price/Book(x)54.695.611.653.323.57
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)
   EV/Core EBITDA(x)0.00-1617.74-695.60-1519.86-264.69
   EV/EBIT(x)0.00-1617.74-695.60-1519.86-264.69
   EV/CE(x)54.005.531.573.310.20
   M Cap / Sales
Growth Ratio
   Net Sales Growth(%)-100.00
   Core EBITDA Growth(%)-0.28-35.39-16.76-293.66-3268.55
   EBIT Growth(%)-0.28-35.39-16.76-293.66-3268.55
   PAT Growth(%)0.08-35.73-16.84-293.20-3635.88
   EPS Growth(%)21.53-35.73-16.7287.29-3635.88
Financial Stability Ratios
   Total Debt/Equity(x)0.010.000.130.000.14
   Current Ratio(x)60.7845.381.001.8123.06
   Quick Ratio(x)60.7845.381.003.1723.06
   Interest Cover(x)-3866.11-260.17-752.16-1664.71-4757.36
   Total Debt/Mcap(x)0.000.000.080.000.04

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.